BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Collins J, Noble S, Chester J, Coles B, Byrne A. The assessment and impact of sarcopenia in lung cancer: a systematic literature review. BMJ Open 2014;4:e003697. [PMID: 24384894 DOI: 10.1136/bmjopen-2013-003697] [Cited by in Crossref: 55] [Cited by in F6Publishing: 60] [Article Influence: 6.9] [Reference Citation Analysis]
Number Citing Articles
1 Hervochon R, Bobbio A, Guinet C, Mansuet-lupo A, Rabbat A, Régnard J, Roche N, Damotte D, Iannelli A, Alifano M. Body Mass Index and Total Psoas Area Affect Outcomes in Patients Undergoing Pneumonectomy for Cancer. The Annals of Thoracic Surgery 2017;103:287-95. [DOI: 10.1016/j.athoracsur.2016.06.077] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 8.0] [Reference Citation Analysis]
2 Tang T, Xie L, Hu S, Tan L, Lei X, Luo X, Yang L, Yang M. Serum creatinine and cystatin C-based diagnostic indices for sarcopenia in advanced non-small cell lung cancer. J Cachexia Sarcopenia Muscle 2022;13:1800-10. [PMID: 35297568 DOI: 10.1002/jcsm.12977] [Reference Citation Analysis]
3 Noble S. Are new anticoagulants a safe and reasonable alternative to low molecular heparins? Thromb Res 2018;164 Suppl 1:S157-61. [PMID: 29703476 DOI: 10.1016/j.thromres.2018.01.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
4 Abumossalam A, Elhadidy T, Ali R, Ibrahim D, Shebl A. Pleural carnal attrition: Sarcopenia and protein catabolism in malignant pleural effusion. Egyptian Journal of Chest Diseases and Tuberculosis 2016;65:421-7. [DOI: 10.1016/j.ejcdt.2016.01.010] [Reference Citation Analysis]
5 Yang M, Shen Y, Tan L, Li W. Prognostic Value of Sarcopenia in Lung Cancer: A Systematic Review and Meta-analysis. Chest 2019;156:101-11. [PMID: 31128115 DOI: 10.1016/j.chest.2019.04.115] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 12.7] [Reference Citation Analysis]
6 Matsuo Y, Mitsuyoshi T, Shintani T, Iizuka Y, Mizowaki T. Impact of low skeletal muscle mass on non-lung cancer mortality after stereotactic body radiotherapy for patients with stage I non-small cell lung cancer. Journal of Geriatric Oncology 2018;9:589-93. [DOI: 10.1016/j.jgo.2018.05.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
7 van Vugt JL, Levolger S, Gharbharan A, Koek M, Niessen WJ, Burger JW, Willemsen SP, de Bruin RW, IJzermans JN. A comparative study of software programmes for cross-sectional skeletal muscle and adipose tissue measurements on abdominal computed tomography scans of rectal cancer patients. J Cachexia Sarcopenia Muscle 2017;8:285-97. [PMID: 27897414 DOI: 10.1002/jcsm.12158] [Cited by in Crossref: 89] [Cited by in F6Publishing: 83] [Article Influence: 14.8] [Reference Citation Analysis]
8 Martin D, von der Grün J, Rödel C, Fokas E. Sarcopenia Is Associated With Hematologic Toxicity During Chemoradiotherapy in Patients With Anal Carcinoma. Front Oncol 2020;10:1576. [PMID: 32903529 DOI: 10.3389/fonc.2020.01576] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ban WH, Yeo CD, Han S, Kang HS, Park CK, Kim JS, Kim JW, Kim SJ, Lee SH, Kim SK. Impact of smoking amount on clinicopathological features and survival in non-small cell lung cancer. BMC Cancer 2020;20:848. [PMID: 32883225 DOI: 10.1186/s12885-020-07358-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Wendrich AW, Swartz JE, Bril SI, Wegner I, de Graeff A, Smid EJ, de Bree R, Pothen AJ. Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer. Oral Oncology 2017;71:26-33. [DOI: 10.1016/j.oraloncology.2017.05.012] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 16.4] [Reference Citation Analysis]
11 Deng HY, Zha P, Zhou Q. Sarcopenia: an unneglectable nutritional status for patients with surgically treated non-small-cell lung cancer. Eur J Cardiothorac Surg 2019;56:420. [PMID: 30561579 DOI: 10.1093/ejcts/ezy435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Yang M, Jiang J, Zeng Y, Tang H. Sarcopenia for predicting mortality among elderly nursing home residents: SARC-F versus SARC-CalF. Medicine (Baltimore) 2019;98:e14546. [PMID: 30762799 DOI: 10.1097/MD.0000000000014546] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
13 Bayly JL, Lloyd-williams M. Identifying functional impairment and rehabilitation needs in patients newly diagnosed with inoperable lung cancer: a structured literature review. Support Care Cancer 2016;24:2359-79. [DOI: 10.1007/s00520-015-3066-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
14 Tsukagoshi M, Yokobori T, Yajima T, Maeno T, Shimizu K, Mogi A, Araki K, Harimoto N, Shirabe K, Kaira K. Skeletal muscle mass predicts the outcome of nivolumab treatment for non-small cell lung cancer. Medicine (Baltimore) 2020;99:e19059. [PMID: 32049805 DOI: 10.1097/MD.0000000000019059] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
15 Sun C, Anraku M, Karasaki T, Kuwano H, Nagayama K, Nitadori J, Sato M, Nakajima J. Low truncal muscle area on chest computed tomography: a poor prognostic factor for the cure of early-stage non-small-cell lung cancer†. European Journal of Cardio-Thoracic Surgery 2019;55:414-20. [DOI: 10.1093/ejcts/ezy324] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
16 Kim EY, Kim YS, Park I, Ahn HK, Cho EK, Jeong YM. Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer. Journal of Thoracic Oncology 2015;10:1795-9. [DOI: 10.1097/jto.0000000000000690] [Cited by in Crossref: 92] [Cited by in F6Publishing: 54] [Article Influence: 13.1] [Reference Citation Analysis]
17 Shen Y, Wang Y, Shi Q, Hou L, Chen X, Dong B, Hao Q. The Electronic Frailty Index is Associated with Increased Infection and All-Cause Mortality Among Older Patients with Primary Lung Cancer: A Cohort Study. Clin Interv Aging 2021;16:1825-33. [PMID: 34675497 DOI: 10.2147/CIA.S335172] [Reference Citation Analysis]
18 Hino H, Saito T, Matsui H, Taniguchi Y, Murakawa T. Utility of Geriatric Nutritional Risk Index in patients with lung cancer undergoing surgery. European Journal of Cardio-Thoracic Surgery 2020;58:775-82. [DOI: 10.1093/ejcts/ezaa066] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
19 Joffe L, Dwyer S, Glade Bender JL, Frazier AL, Ladas EJ. Nutritional status and clinical outcomes in pediatric patients with solid tumors : A systematic review of the literature. Semin Oncol 2019;46:48-56. [PMID: 30655021 DOI: 10.1053/j.seminoncol.2018.11.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
20 Ryan B, Hennon M, Yendamuri S. Editorial: refining the estimation of fitness for surgery. J Thorac Dis 2018;10:S3195-7. [PMID: 30370110 DOI: 10.21037/jtd.2018.08.35] [Reference Citation Analysis]
21 Ramdass V, Caskey E, Sklarz T, Ajmeri S, Patel V, Balogun A, Pomary V, Hall J, Qari O, Tripathi R, Hunter K, Roy S. Association Between Obesity and Cancer Mortality: An Internal Medicine Outpatient Clinic Perspective. J Clin Med Res 2021;13:377-86. [PMID: 34394780 DOI: 10.14740/jocmr4543] [Reference Citation Analysis]
22 Fairman CM, Kendall KL, Hart NH, Taaffe DR, Galvão DA, Newton RU. The potential therapeutic effects of creatine supplementation on body composition and muscle function in cancer. Crit Rev Oncol Hematol 2019;133:46-57. [PMID: 30661658 DOI: 10.1016/j.critrevonc.2018.11.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
23 Joffe L, Shen W, Shadid G, Jin Z, Ladas EJ. Skeletal muscle and adipose tissue changes in the first phase of treatment of pediatric solid tumors. Cancer Med 2021;10:15-22. [PMID: 33140912 DOI: 10.1002/cam4.3584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Goncalves MD, Taylor S, Halpenny DF, Schwitzer E, Gandelman S, Jackson J, Lukose A, Plodkowski AJ, Tan KS, Dunphy M, Jones LW, Downey RJ. Imaging skeletal muscle volume, density, and FDG uptake before and after induction therapy for non-small cell lung cancer. Clin Radiol 2018;73:505.e1-8. [PMID: 29317048 DOI: 10.1016/j.crad.2017.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
25 Joffe L, Schadler KL, Shen W, Ladas EJ. Body Composition in Pediatric Solid Tumors: State of the Science and Future Directions. J Natl Cancer Inst Monogr 2019;2019:144-8. [PMID: 31532526 DOI: 10.1093/jncimonographs/lgz018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
26 Suzuki Y, Okamoto T, Fujishita T, Katsura M, Akamine T, Takamori S, Morodomi Y, Tagawa T, Shoji F, Maehara Y. Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer. Lung Cancer 2016;101:92-7. [DOI: 10.1016/j.lungcan.2016.08.007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 64] [Article Influence: 9.5] [Reference Citation Analysis]
27 Bryl B, Merrix S, Proud D, Marin A, Byrne A, Duckers J. Are We Missing the Opportunity to Measure Muscle Mass on Computed Tomography Thorax? J Thorac Imaging 2021;36:W32-3. [PMID: 32349054 DOI: 10.1097/RTI.0000000000000517] [Reference Citation Analysis]
28 Keller K. Sarcopenia. Wien Med Wochenschr 2019;169:157-72. [DOI: 10.1007/s10354-018-0618-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
29 Kim EY, Kim K, Kim YS, Ahn HK, Jeong YM, Kim JH, Choi W. Prevalence of and Factors Associated with Sarcopenia in Korean Cancer Survivors: Based on Data Obtained by the Korea National Health and Nutrition Examination Survey (KNHANES) 2008–2011. Nutrition and Cancer 2017;69:394-401. [DOI: 10.1080/01635581.2017.1267776] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
30 Shoji F. Clinical impact of preoperative immunonutritional status in patients undergoing surgical resection of lung cancer. J Thorac Dis 2019;11:S408-12. [PMID: 30997233 DOI: 10.21037/jtd.2018.11.118] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
31 Zhao Y, Zhang Y, Hao Q, Ge M, Dong B. Sarcopenia and hospital-related outcomes in the old people: a systematic review and meta-analysis. Aging Clin Exp Res 2019;31:5-14. [PMID: 29549649 DOI: 10.1007/s40520-018-0931-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
32 Baxi SS, Schwitzer E, Jones LW. A review of weight loss and sarcopenia in patients with head and neck cancer treated with chemoradiation. Cancers Head Neck 2016;1:9. [PMID: 31093339 DOI: 10.1186/s41199-016-0010-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
33 Go SI, Park MJ, Song HN, Kang MH, Park HJ, Jeon KN, Kim SH, Kim MJ, Kang JH, Lee GW. Sarcopenia and inflammation are independent predictors of survival in male patients newly diagnosed with small cell lung cancer. Support Care Cancer 2016;24:2075-84. [PMID: 26546456 DOI: 10.1007/s00520-015-2997-x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 8.9] [Reference Citation Analysis]
34 Woo HY, Oh SY, Lee H, Ryu HG. Evaluation of the association between decreased skeletal muscle mass and extubation failure after long-term mechanical ventilation. Clin Nutr 2020;39:2764-70. [PMID: 31917051 DOI: 10.1016/j.clnu.2019.12.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
35 Granger CL, Edbrooke L, Denehy L. The nexus of functional exercise capacity with health-related quality of life in lung cancer: how closely are they related? Ann Transl Med 2018;6:S131. [PMID: 30740452 DOI: 10.21037/atm.2018.12.35] [Reference Citation Analysis]
36 Choe EK, Lee Y, Kang HY, Choi SH, Kim JS. Association between CT-Measured Abdominal Skeletal Muscle Mass and Pulmonary Function. J Clin Med 2019;8:E667. [PMID: 31083639 DOI: 10.3390/jcm8050667] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
37 Fidler MJ, Frankenberger C, Seto R, Lobato GC, Fhied CL, Sayidine S, Basu S, Pool M, Karmali R, Batus M, Lie WR, Hayes D, Mistry J, Bonomi P, Borgia JA. Differential expression of circulating biomarkers of tumor phenotype and outcomes in previously treated non-small cell lung cancer patients receiving erlotinib vs. cytotoxic chemotherapy. Oncotarget 2017;8:58108-21. [PMID: 28938541 DOI: 10.18632/oncotarget.17510] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
38 Shin HS, Choi DS, Na JB, Choi HY, Kim JE, Choi HC, Won JH, Lee SJ, Park MJ. Low pectoralis muscle index, cavitary nodule or mass and segmental to lobar consolidation as predictors of primary multidrug-resistant tuberculosis: A comparison with primary drug sensitive tuberculosis. PLoS One 2020;15:e0239431. [PMID: 33017424 DOI: 10.1371/journal.pone.0239431] [Reference Citation Analysis]
39 Miyamoto Y, Baba Y, Sakamoto Y, Ohuchi M, Tokunaga R, Kurashige J, Hiyoshi Y, Iwagami S, Yoshida N, Watanabe M, Baba H. Negative Impact of Skeletal Muscle Loss after Systemic Chemotherapy in Patients with Unresectable Colorectal Cancer. PLoS One. 2015;10:e0129742. [PMID: 26069972 DOI: 10.1371/journal.pone.0129742] [Cited by in Crossref: 86] [Cited by in F6Publishing: 81] [Article Influence: 12.3] [Reference Citation Analysis]
40 Recio-Boiles A, Galeas JN, Goldwasser B, Sanchez K, Man LMW, Gentzler RD, Gildersleeve J, Hollen PJ, Gralla RJ. Enhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT). Support Care Cancer 2018;26:2353-9. [PMID: 29417293 DOI: 10.1007/s00520-018-4051-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
41 Vanhove K, Graulus GJ, Mesotten L, Thomeer M, Derveaux E, Noben JP, Guedens W, Adriaensens P. The Metabolic Landscape of Lung Cancer: New Insights in a Disturbed Glucose Metabolism. Front Oncol 2019;9:1215. [PMID: 31803611 DOI: 10.3389/fonc.2019.01215] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 6.7] [Reference Citation Analysis]
42 Trestini I, Gkountakos A, Carbognin L, Avancini A, Lanza M, Molfino A, Friso S, Corbo V, Tortora G, Scarpa A, Milella M, Bria E, Pilotto S. Muscle derangement and alteration of the nutritional machinery in NSCLC. Critical Reviews in Oncology/Hematology 2019;141:43-53. [DOI: 10.1016/j.critrevonc.2019.06.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
43 Taylor JM, Song A, David AR, Chen VE, Lu B, Werner-Wasik M. Impact of Sarcopenia on Survival in Patients With Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy. Cureus 2020;12:e10712. [PMID: 33014666 DOI: 10.7759/cureus.10712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Deng H, Hou L, Zha P, Huang K, Peng L. Sarcopenia is an independent unfavorable prognostic factor of non-small cell lung cancer after surgical resection: A comprehensive systematic review and meta-analysis. European Journal of Surgical Oncology 2019;45:728-35. [DOI: 10.1016/j.ejso.2018.09.026] [Cited by in Crossref: 28] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
45 Vergidis J, Gresham G, Lim HJ, Renouf DJ, Kennecke HF, Ruan JY, Chang JT, Cheung WY. Impact of Weight Changes After the Diagnosis of Stage III Colon Cancer on Survival Outcomes. Clin Colorectal Cancer 2016;15:16-23. [PMID: 26281943 DOI: 10.1016/j.clcc.2015.07.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
46 Indrakusuma R, Zijlmans JL, Jalalzadeh H, Planken RN, Balm R, Koelemay MJW. Psoas Muscle Area as a Prognostic Factor for Survival in Patients with an Asymptomatic Infrarenal Abdominal Aortic Aneurysm: A Retrospective Cohort Study. Eur J Vasc Endovasc Surg. 2018;55:83-91. [PMID: 29158067 DOI: 10.1016/j.ejvs.2017.10.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
47 Mallet R, Decazes P, Modzelewski R, Lequesne J, Vera P, Dubray B, Thureau S. Prognostic value of low skeletal muscle mass in patient treated by exclusive curative radiochemotherapy for a NSCLC. Sci Rep 2021;11:10628. [PMID: 34017035 DOI: 10.1038/s41598-021-90187-6] [Reference Citation Analysis]
48 Gea J, Sancho-Muñoz A, Chalela R. Nutritional status and muscle dysfunction in chronic respiratory diseases: stable phase versus acute exacerbations. J Thorac Dis 2018;10:S1332-54. [PMID: 29928517 DOI: 10.21037/jtd.2018.02.66] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
49 Pérez Camargo DA, Allende Pérez SR, Verastegui Avilés E, Rivera Franco MM, Meneses García A, Herrera Gómez Á, Urbalejo Ceniceros VI. Assessment and Impact of Phase Angle and Sarcopenia in Palliative Cancer Patients. Nutrition and Cancer 2017;69:1227-33. [DOI: 10.1080/01635581.2017.1367939] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
50 Nakada T, Noda Y, Kato D, Shibasaki T, Mori S, Asano H, Matsudaira H, Hirano J, Odaka M, Ohtsuka T. Risk factors and cancer recurrence associated with postoperative complications after thoracoscopic lobectomy for clinical stage I non-small cell lung cancer. Thorac Cancer 2019;10:1945-52. [PMID: 31436042 DOI: 10.1111/1759-7714.13173] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
51 Hansen TTD, Omland LH, von Heymann A, Johansen C, Clausen MB, Suetta C, Pappot H, Rafn BS. Development of Sarcopenia in Patients With Bladder Cancer: A Systematic Review. Semin Oncol Nurs 2021;37:151108. [PMID: 33431235 DOI: 10.1016/j.soncn.2020.151108] [Reference Citation Analysis]
52 Kim EY, Kim YS, Seo JY, Park I, Ahn HK, Jeong YM, Kim JH, Kim N. The Relationship between Sarcopenia and Systemic Inflammatory Response for Cancer Cachexia in Small Cell Lung Cancer. PLoS One 2016;11:e0161125. [PMID: 27537502 DOI: 10.1371/journal.pone.0161125] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
53 Krenzlin H, Schmidt L, Jankovic D, Schulze C, Brockmann MA, Ringel F, Keric N. Impact of Sarcopenia and Bone Mineral Density on Implant Failure after Dorsal Instrumentation in Patients with Osteoporotic Vertebral Fractures. Medicina 2022;58:748. [DOI: 10.3390/medicina58060748] [Reference Citation Analysis]
54 Choi YI, Chung JW, Park DK, Ko KP, Kim KO, Kwon KA, Kim JH, Kim YJ. Sarcopenia is Independently Associated with an Increased Risk of Peptic Ulcer Disease: A Nationwide Population-Based Study. Medicina (Kaunas) 2020;56:E121. [PMID: 32168799 DOI: 10.3390/medicina56030121] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Nigro E, Perrotta F, Scialò F, D'Agnano V, Mallardo M, Bianco A, Daniele A. Food, Nutrition, Physical Activity and Microbiota: Which Impact on Lung Cancer? Int J Environ Res Public Health 2021;18:2399. [PMID: 33804536 DOI: 10.3390/ijerph18052399] [Reference Citation Analysis]
56 Matsuyama R, Maeda K, Yamanaka Y, Ishida Y, Nonogaki T, Kato R, Shimizu A, Ueshima J, Kazaoka Y, Hayashi T, Ito K, Furuhashi A, Ono T, Mori N. Evaluation of skeletal muscle mass using prediction formulas at the level of the 12th thoracic vertebra. Nutrition 2021;93:111475. [PMID: 34638102 DOI: 10.1016/j.nut.2021.111475] [Reference Citation Analysis]
57 Icard P, Schussler O, Loi M, Bobbio A, Lupo AM, Wislez M, Iannelli A, Fournel L, Damotte D, Alifano M. Pre-Disease and Pre-Surgery BMI, Weight Loss and Sarcopenia Impact Survival of Resected Lung Cancer Independently of Tumor Stage. Cancers (Basel) 2020;12:E266. [PMID: 31979060 DOI: 10.3390/cancers12020266] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
58 Kim EY, Kim YJ, Kim YS, Kim KW, Jeon JY, Kim KG. Prognostic significance of radiodensity-based skeletal muscle quantification using preoperative CT in resected non-small cell lung cancer. J Thorac Dis 2021;13:754-61. [PMID: 33717547 DOI: 10.21037/jtd-20-2344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Yamahara K, Mizukoshi A, Lee K, Ikegami S. Sarcopenia with inflammation as a predictor of survival in patients with head and neck cancer. Auris Nasus Larynx 2021;48:1013-22. [PMID: 33883097 DOI: 10.1016/j.anl.2021.03.021] [Reference Citation Analysis]
60 Kim CR, Kim EY, Kim YS, Ahn HK, Kim KW, Jeong YM, Kim JH. Histologic subtypes are not associated with the presence of sarcopenia in lung cancer. PLoS One 2018;13:e0194626. [PMID: 29590170 DOI: 10.1371/journal.pone.0194626] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
61 Tsang NM, Pai PC, Chuang CC, Chuang WC, Tseng CK, Chang KP, Yen TC, Lin JD, Chang JT. Overweight and obesity predict better overall survival rates in cancer patients with distant metastases. Cancer Med 2016;5:665-75. [PMID: 26811258 DOI: 10.1002/cam4.634] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
62 Detopoulou P, Voulgaridou G, Papadopoulou S. Cancer, Phase Angle and Sarcopenia: The Role of Diet in Connection with Lung Cancer Prognosis. Lung 2022. [PMID: 35616720 DOI: 10.1007/s00408-022-00536-z] [Reference Citation Analysis]
63 Lee JH, Jee BA, Kim JH, Bae H, Chung JH, Song W, Sung HH, Jeon HG, Jeong BC, Seo SI, Jeon SS, Lee HM, Park SH, Kang M. Prognostic Impact of Sarcopenia in Patients with Metastatic Hormone-Sensitive Prostate Cancer. Cancers (Basel) 2021;13:6345. [PMID: 34944964 DOI: 10.3390/cancers13246345] [Reference Citation Analysis]
64 Atlan P, Bayar MA, Lanoy E, Besse B, Planchard D, Ramon J, Raynard B, Antoun S. Factors which modulate the rates of skeletal muscle mass loss in non-small cell lung cancer patients: a pilot study. Support Care Cancer 2017;25:3365-73. [PMID: 28593463 DOI: 10.1007/s00520-017-3755-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
65 Kim EY, Lee HY, Kim KW, Lee J, Kim YS, Choi W, Kim JH. Preoperative Computed Tomography–Determined Sarcopenia and Postoperative Outcome After Surgery for Non-Small Cell Lung Cancer. Scand J Surg 2018;107:244-51. [DOI: 10.1177/1457496917748221] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
66 Derman BA, Macklis JN, Azeem MS, Sayidine S, Basu S, Batus M, Esmail F, Borgia JA, Bonomi P, Fidler MJ. Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer. BMC Cancer 2017;17:141. [PMID: 28209123 DOI: 10.1186/s12885-017-3122-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
67 Endo K, Ueno T, Hirai N, Komori T, Nakanishi Y, Kondo S, Wakisaka N, Yoshizaki T. Low Skeletal Muscle Mass Is a Risk Factor for Aspiration Pneumonia During Chemoradiotherapy. Laryngoscope 2021;131:E1524-9. [PMID: 33030229 DOI: 10.1002/lary.29165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
68 Icard P, Iannelli A, Lincet H, Alifano M. Sarcopenia in resected non-small cell lung cancer: let's move to patient-directed strategies. J Thorac Dis 2018;10:S3138-42. [PMID: 30370098 DOI: 10.21037/jtd.2018.08.34] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]